Skip to main content

Coming 2026: AI-Powered Precision Care for Women’s Chronic Gynecological Conditions

One Platform. One Unified Data Ecosystem. Complete Care and Research

ENDOless transforms lived experience into actionable insights and breakthrough research — supporting women with endometriosis, PCOS, PMS, pelvic pain, and beyond. Our privacy-first AI companion empowers every woman to reclaim control over her health journey, while fueling science that finally understands her

Join Early Access
Partner with Us

The Crisis: A System That Doesn’t See Women

This is a crisis of data, diagnosis, and design — but most importantly, a crisis of trust and visibility

Economic Impact Healthcare Costs Productivity Loss
$15,000 $8,000 28%
Annual cost per woman Annual medical costs Decrease during periods
69% miss work monthly 4x diabetes risk $1,986 lost earnings/year
38% reduced productivity 3x heart disease risk 9 missed days/year
Endometriosis PCOS Period Issues
190M 116M 500M
Women affected worldwide Women with PCOS globally Face period poverty
7–12 years to diagnosis 70% undiagnosed Limited tracking tools
Workplace Impact Treatment Costs
23% $12,000
Performance decline Annual healthcare costs
$4,333 annual impact 50% work limitations
12% absenteeism increase 6.2 doctor visits/year
PMS Pelvic Pain
85% 15%
Women experience PMS symptoms Women have chronic pelvic pain
Often untreated Frequently dismissed

Frequently Asked Questions

 

When will ENDOless be available?

ENDOless is currently in beta and plans a full public launch in Q1 2026. Join our waitlist to get early access and help shape the product

How is ENDOless different from other period tracking apps?

ENDOless goes far beyond basic period tracking by focusing on chronic gynecological conditions like endometriosis and PCOS. Our AI-powered platform predicts flare-ups, delivers personalized insights, and generates research-grade, privacy-protected data to improve care and accelerate medical breakthroughs

What is ENDOless’s business model?

We operate on three revenue streams: a freemium subscription app for women (B2C), a SaaS platform for employers to support workforce wellbeing (B2B), and a Research-as-a-Service model licensing anonymized real-world data to pharma and academic researchers

How does ENDOless protect my data?

Privacy is at our core. ENDOless is built with GDPR-by-design principles, ensuring your health data is securely stored, anonymized, and only shared with your explicit consent. We never sell your data and comply with all global privacy regulations

Can I invest in or partner with ENDOless?

Absolutely! We welcome investors and partners aligned with our mission to revolutionize women’s health. Contact us via contact@endoless.app to learn more about collaboration opportunities

Who can use ENDOless?

ENDOless is designed for women with chronic gynecological conditions, employers aiming to improve employee wellbeing, and researchers seeking high-quality real-world data to drive innovation

Is ENDOless suitable for all women’s health conditions?

Our initial focus is on endometriosis, PCOS, PMS, and chronic pelvic pain, but we are building the platform to support a broad range of gynecological and autoimmune conditions over time